Is Berkshire Hathaway Stock a Buy Right Now?

Greg Abel succeeded Warren Buffett as Berkshire Hathaway CEO after Buffett's retirement at the end of 2025; BRK shares are down ~4.2% YTD and ~8% over the past 12 months. Berkshire ended the year with $373 billion in cash and remained a net seller in the most recent quarter; Abel's first quarter under his leadership will report on May 2 (first shareholders' meeting around that time). Management changes across insurance/non-insurance operations and a forthcoming CFO transition create short-term uncertainty, but the piece argues value-oriented deployment of the cash hoard could produce investment opportunities and views the company as a solid buy under Abel.

Analysis

A governance handoff at a mega-cap conglomerate changes the probability distribution of capital allocation without needing to change operating performance. The most important second-order effect is not an immediate return re-rate but a change in dealflow: many mid-market industrials, insurance franchises and specialty finance platforms become economically buyable once the new regime signals willingness to deploy large scale capital, which should compress takeover premia for those targets and lift M&A advisors and private-equity co-investment opportunities.

Tail risk centers on capital misallocation and insurance reserve volatility. If new leadership accelerates activity to make a mark, the short-run drag from integration costs or earnings buy vs build choices could depress reported ROIC for 6–18 months; conversely, a disciplined buyback program sized aggressively would mechanically lift EPS and produce a faster rerating within 3–9 months. Useful observable metrics to watch are acquisition spend as a % of market cap, repurchases per share, underwriting combined ratios, and realized ROIC on any announced deals — each will move investor sentiment quickly.

From a positioning standpoint, this is a classic idiosyncratic-event trade that benefits from being delta-hedged to the market move. The opportunity set also creates asymmetry for broker-dealers, M&A boutiques and specialty insurers: if management chooses large public deals, expect cross-asset liquidity events (block trades, accelerated book builds) that create short-lived windows of outperformance for liquidity providers and exchange operators.

Key Decisions for Investors

• Initiate a 1–2% portfolio position long BRKB stock and hedge market beta by shorting S&P 500 futures to achieve ~0.2 net beta exposure. Timeframe: 3–12 months. R/R: target 15–25% idiosyncratic upside if active capital deployment or buybacks occur; hard stop at 10% loss on the unhedged position.
• Buy a 9–12 month BRKB call-debit spread sized to 1% portfolio (buy near-the-money call / sell +12–18% call) to capture a potential acquisition/buyback surprise with capped premium risk. Timeframe: 3–9 months. R/R: asymmetric payout (2–4x on premium) if a material capital allocation announcement occurs; max loss = premium paid.
• Go long NDAQ (1% position) to capture higher trading, listing and M&A advisory flow from increased deal activity and shareholder events. Timeframe: 6–12 months. R/R: expect ~15–25% upside if volumes and advisory pipelines expand; downside risk ~10–12% tied to market-wide weakness.
• Pair trade for rotation risk: long BRKB / short a high-multiple growth name (e.g., small-size short NFLX) in dollar-neutral weights to isolate value-rotation alpha. Timeframe: 6–12 months. R/R: designed to capture spread compression (target 10–20% spread move) with limited market beta; risk if broad market growth rally continues, cap position size to <1% net exposure.